Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$9.04
+2.61%
(+0.23) 1D
Apr 24, 4:10:25 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CUV...
Open
A$8.80
High
A$9.06
Low
A$8.62
Mkt. cap
455.87M
Avg. vol.
103.22K
Volume
101.19K
Dividend
0.55%
Quarterly dividend
A$0.01
Ex dividend date
Sep 4, 2025
P/E ratio
14.04
52-wk high
A$14.00
52-wk low
A$8.62
EPS
A$0.64
Shares outstanding
50.43M
No. of employees
16
News stories
From sources across the web
About Clinuvel Pharmaceuticals Ltd
CEO-
Employees16
Founded1999
Headquarters-
SectorBiotechnology
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
29.68M
29.68M
18.47M
18.47M
Cost of goods sold
2.71M
2.71M
2.28M
2.28M
Cost of revenue
2.71M
2.71M
2.28M
2.28M
Research and development expenses
2.28M
2.28M
1.70M
1.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.18M
9.18M
6.96M
6.96M
Operating expense
12.23M
12.23M
9.42M
9.42M
Total operating expenses
14.94M
14.94M
11.71M
11.71M
Operating income
14.74M
14.74M
6.76M
6.76M
Other non operating income
-
-
-
-
EBT including unusual items
14.81M
14.81M
7.29M
7.29M
EBT excluding unusual items
14.81M
14.81M
7.29M
7.29M
Income tax expense
3.76M
3.76M
2.07M
2.07M
Effective tax rate
25.40%
25.40%
28.39%
28.39%
Other operating expenses
-12.09K
-12.09K
-1.24K
-1.24K
Net income
11.05M
11.05M
5.22M
5.22M
Net profit margin
37.22%
37.22%
28.28%
28.28%
Earnings per share
-
-
-
-
Interest and investment income
2.41M
2.41M
2.63M
2.63M
Interest expense
-1.24M
-1.24M
-1.28M
-1.28M
Net interest expenses
1.16M
1.16M
1.35M
1.35M
Depreciation and amortization charges
286.78K
286.78K
250.02K
250.02K
EBITDA
14.83M
14.83M
7.01M
7.01M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more